Month: October 2020

Some investors rely on dividends for growing their wealth, and if you’re one of those dividend sleuths, you might be… …read more […]

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will… …read more […]

Stock futures pointed sharply lower Monday morning as new data showed a jump in COVID-19 cases in both the U.S. and Europe. Restrictions tightened across major countries overseas, raising the specter of a further pullback in business operations and deeper anchor on global economic activity. …read more […]

Those following along with Selecta Biosciences, Inc. (NASDAQ:SELB) will no doubt be intrigued by the recent purchase… …read more […]

(Bloomberg) — Libya is set to restart the last of its major oil fields following a ceasefire in its civil war, a milestone for the OPEC member that’s been largely offline since January.Oil dropped after the state energy firm lifted force majeure on exports from El Feel on Monday. The move will bolster the Tripoli-based National Oil Corp.’s attempt to boost Libyan production to 1 million barrels each day within a month.The return of Libyan barrels is hindering OPEC+ as it tries to prop up crude prices amid a resurgence in coronavirus cases and with many major economies imposing lockdowns …read more […]

The last three months have been tough on Altimmune, Inc. (NASDAQ:ALT) shareholders, who have seen the share price… …read more […]

Citigroup Inc. (NYSE:C) stock is about to trade ex-dividend in three days. Ex-dividend means that investors that… …read more […]

(Bloomberg Opinion) — Heading into last Friday, there was no shortage of superlatives to describe the rise in long-term yields in the $20.4 trillion U.S. Treasury market. Just to name a few:The yield curve from five to 30 years steepened to 130 basis points, the widest gap since Nov. 16, 2016. The benchmark 10-year Treasury yield had climbed for six consecutive trading sessions, the longest stretch since September 2019. At 0.868%, the 10-year yield reached its highest level in more than four months and briefly broke above its 200-day moving average from below for the first time since late 2017. …read more […]

Top news and what to watch in the markets on Monday, October 26, 2020. …read more […]

(Bloomberg) — Bayer AG agreed to acquire U.S. biotech company Asklepios BioPharmaceutical Inc. for as much as $4 billion, bolstering its pharma division with experimental gene therapies before patents expire on some key drugs.The German chemicals giant will pay $2 billion upfront and another $2 billion in potential milestone payments in cash for closely held AskBio, a North Carolina-based company that’s developing gene therapies for ailments such as Parkinson’s disease and congestive heart failure.Bayer is expanding in the cutting-edge field of gene and cell therapies at a time when its blockbuster drugs age and the company’s crop-protection business reels from …read more […]

(Bloomberg) — Coca-Cola European Partners Plc agreed to buy Australian bottler Coca-Cola Amatil Ltd., creating a global producer of packaged beverages to better withstand a slowdown in the industry and the shift away from sugary drinks.The purchase values Sydney-based Coca-Cola Amatil at A$9.23 billion ($6.6 billion), a 19% premium to where its shares traded last week. The target’s board intends to unanimously recommend the offer.The A$12.75-per-share cash deal would double the European company’s potential market at a stroke, putting almost 300 million consumers within reach in the Southern Hemisphere, including the key developing nation of Indonesia.Such growth opportunities are all …read more […]

Oct.26 — President Donald Trump enters the final week before Election Day with a surge in U.S. coronavirus cases and another White House outbreak after several people in Vice President Mike Pence’s inner circle contracted Covid-19. Joe Biden will travel to Georgia on Tuesday, the Democratic presidential nominee’s first campaign trip to a state that hasn’t voted for a Democrat since 1992 but one where polls show a tight race. Kathleen Hunter reports on “Bloomberg Markets: European Open.” …read more […]

…read more […]

(Bloomberg) — Investors wondering how China plans to evolve its financial markets in the coming years need look no further than the commentary from the weekend’s Bund Summit in Shanghai for guidance.People’s Bank of China Governor Yi Gang said that promoting broader use of the yuan will continue alongside the opening of financial markets. “The regulator’s main job is to reduce restrictions on the cross-border use of the currency, and let it take its own course,” he said.Those comments were echoed by Zhu Jun, director general of the central bank’s international division. Policy makers will remove obstacles that stand in …read more […]

Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses. Germany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements, it said on Monday. The North Carolina-based takeover target, also known as AskBio, is trying to use the harmless adeno-associated virus as a delivery device to bring genetic repair kits against a range of diseases into the body.Drugs and farming pesticides maker Bayer needs to upgrade its …read more […]